Industry
Drug Manufacturers - Specialty & GenericSector
HealthcareNumber of Employees
21Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.
About Petros Pharmaceuticals
Website: https://www.petrospharma.com
CEO (Chief Executive Officer): Mr. Fady Boctor M.B.A.
IPO date: 2020-12-02
Contact
Country: US
Address: 1185 Avenue of the Americas
City: New York
State: NY
Phone: 973-242-0005
Zip Code: 10036
Other
CIK: 0001815903
ISIN: US71678J2096
CUSIP: 71678J100